BiotechTube
Home/Cassava Sciences/Remi Barbier
RB

Remi Barbier

President, CEO & Chairman

Cassava Sciences

Therapeutic Areas

Alzheimer's DiseaseNeurodegenerative Diseases

Cassava Sciences Pipeline

DrugIndicationPhase
Simufilam (PTI-125)Alzheimer's Disease DementiaPhase 3
SavaDxAlzheimer's Disease DetectionResearch

Leadership Team at Cassava Sciences

EJ
Eric J. Schoen
Chief Financial Officer
JS
James S. (Jim) Burns
Chief Operating Officer
LA
Lindsay A. Burns
Senior Vice President, Neuroscience
View full Cassava Sciences profile